InvestorsHub Logo
Followers 15
Posts 1134
Boards Moderated 0
Alias Born 02/08/2014

Re: None

Tuesday, 03/05/2024 10:03:09 AM

Tuesday, March 05, 2024 10:03:09 AM

Post# of 113601
Buyback and improve balance sheet!
Sunshine Biopharma, Inc. recently reacquired warrants for over 21 million shares of its common stock through two separate agreements, spending a total of approximately $3.14 million. The deals involved buying back May 2023 Warrants for over $2.36 million and April 2022 Warrants at $0.08 each, adding up to $778,055. These transactions led to the cancellation and termination of the warrants, signaling a strategic move by the company to manage its outstanding securities.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News